Martin Elizabeth A, Charkoudian Nisha
Dept. of Physiology and Biomedical Engineering, Mayo Clinic College of Medicine, 200 First Street SW, Rochester (MN) 55905, USA.
Clin Auton Res. 2005 Apr;15(2):121-5. doi: 10.1007/s10286-005-0262-y.
We tested whether central venous pressure (CVP) changes during vasoactive drug injections used for baroreflex assessment in humans. We measured CVP during sequential intravenous boluses of nitroprusside (NTP) and phenylephrine (PHE; modified Oxford technique). NTP caused a decrease in CVP of 1.9+/-0.2 mmHg from baseline (P<0.01) and PHE caused an increase in CVP of 0.3+/-0.2 mmHg above baseline. These changes in CVP may contribute to the observed integrated baroreflex responses.
我们测试了在用于人体压力反射评估的血管活性药物注射过程中中心静脉压(CVP)是否会发生变化。我们在依次静脉推注硝普钠(NTP)和去氧肾上腺素(PHE;改良牛津技术)期间测量了CVP。NTP使CVP较基线水平降低了1.9±0.2 mmHg(P<0.01),PHE使CVP较基线水平升高了0.3±0.2 mmHg。CVP的这些变化可能有助于观察到的综合压力反射反应。